SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 692.55 |
| Enterprise Value ($M) | 918.72 |
| Book Value ($M) | 55.82 |
| Book Value / Share | 1.04 |
| Price / Book | 12.41 |
| NCAV ($M) | -125.85 |
| NCAV / Share | -2.36 |
| Price / NCAV | -5.50 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.44 |
| Return on Assets (ROA) | -0.29 |
| Return on Equity (ROE) | -1.15 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.51 |
| Current Ratio | 6.51 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 464.14 |
| Assets | 645.81 |
| Liabilities | 589.99 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vestal Point Capital, LP | |||
| 13G | EcoR1 Capital, LLC | |||
| 13G/A | Nantahala Capital Management, LLC | |||
| 13G/A | Bristol Myers Squibb Co | 4.90 | 0.00 | |
| 13G/A | Boxer Capital Management, LLC | 4.60 | ||
| 13G/A | State Street Corp | 0.40 | -94.97 | |
| 13G | Boxer Capital, LLC | 5.10 | ||
| 13G/A | Fmr Llc | 0.10 | -98.19 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 59,229 | 695,883 | 8.51 | |
| 37,089 | 270,385 | 13.72 | |
| 71,235 | 484,954 | 14.69 | |
| 66,266 | 586,247 | 11.30 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PYXS – Pyxis Oncology, Inc. | QDEL – QuidelOrtho Corporation |
| QNCX – Quince Therapeutics, Inc. | RARE – Ultragenyx Pharmaceutical Inc. |
| RDUS – Radius Recycling, Inc. |
Financial data and stock pages provided by
Fintel.io